Related Articles
Somatic mutations in glioblastoma are associated with methylguanine-DNA methyltransferase methylation
Predictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving first-line temozolomide plus bevacizumab in the trial SAKK 50/07
Selection of chemotherapy for glioblastoma expressing O6-methylguanine-DNA methyltransferase
Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation: A Portuguese multicentre study
Expression of glioma stem cell marker CD133 and O6-methylguanine-DNA methyltransferase is associated with resistance to radiotherapy in gliomas